The plaintiff's supporting affidavit
20 Dr Chisholm's first affidavit sets out some background to the plaintiff's dealings with the defendant and with the partnership and identifies two parts of the plaintiff's offsetting claim against the defendant company. At the hearing before me, counsel for the plaintiff, Mr Bova, did not read certain paragraphs of Dr Chisholm's affidavit. Mr DeBuse, counsel for the defendant, sought to tender those paragraphs in order to make out an argument that I will discuss further below. Mr Bova initially objected on hearsay grounds, although he accepted that the paragraphs were tendered for a non-hearsay purpose; Evidence Act 1995 (Cth) s 60. He also objected on relevance, arguing that the dispute was confined to those issues identified in the read paragraphs of the affidavit. At the hearing I reserved my decision on that objection and now find, for reasons given below at [32], that the material is relevant.
21 Mr Bova's submission that the dispute was confined to the issues identified in the affidavit as read at the hearing does not take into account the purpose of the requirement in s 459G(3) that the supporting affidavit not only be filed within 21 days of the demand but also that, within that same period, a copy be served on the party making the demand. As Olney J stated in 71 Paisley Street Footscray Pty Ltd v Vineyards Estate Pty Ltd [1995] FCA 635 at [10], the "purpose of the affidavit contemplated by s 459G(3) is to tell the creditor why it is said that the demand should be set aside". It follows that, if the discrepancy between the affidavit as read at the hearing and the affidavit that, in its entirety, had been served on the defendant, is such as to put forward materially different bases for seeking to set aside the statutory demand, the question whether the requirements of s 459G(3) have actually been met must arise.
22 Another difficulty with the affidavit is that it does not distinguish between the defendant and the partnership. It indicates in paragraph 3 that the defendant company will be referred to as "Anar" and then proceeds to refer to dealings with "Anar" (for instance in paragraph 8) that took place before the defendant was incorporated. I can only assume that in such cases Dr Chisholm is referring to the partnership.
23 The dispute between the parties centres on the supply of a particular dye, known in the industry as Direct Blue 290. This dye is a discrete chemical compound which was developed by Ciba Specialty Chemicals in the 1970s. Ciba's patent over the compound expired in the late 1990s. In early 2003, the plaintiff negotiated with Mr Choksi with a view to sourcing a chemical copy of Direct Blue 290. In April of that year, "Anar" (presumably the partnership) sent a sample dye to the plaintiff. The sample was apparently labelled "Direct Blue 290". Accompanying the sample was a material safety data sheet which also identified the product as "Direct Blue 290". Dr Chisholm asked Mr Choksi to carry out stability work on the dye "to ensure the product was stable under Indonesian conditions".
24 Dr Chisholm states that in June 2003 he advised Anar by email that "after their stability result and our shade and cost evaluation the plaintiff could go ahead and order the dye". As read, the affidavit does not explicitly refer to the plaintiff ordering the dye although this is implied by the statement that the Direct Blue 290 dye was "used at the Paper and Pulp Mill of Pindo Delhi [in Indonesia] to produce Printing and Writing Papers for export around the world".
25 Dr Chisholm described how he had to fly to visit the pulp mill to resolve problems caused by the dye thickening which resulted in a loss of production. He was also advised of a possible claim against the plaintiff for the losses incurred by Pindo Delhi. This is the first part of the plaintiff's offsetting claim. Dr Chisholm estimated the costs and expenses incurred or anticipated by the plaintiff as a result of the dye thickening at USD69,500 comprising USD14,000 for air travel, USD1,500 for 9 nights' accommodation, USD4,000 for meals and entertainment and USD50,000 in relation to anticipated claims for loss of paper.
26 The second part of the offsetting claim is based on the allegation that the dye supplied was not Direct Blue 290 as specified by the plaintiff but had a different chemical composition. Dr Chisholm described how in July 2005 he was informed by Mr Ajay Choksi, apparently also representing the defendant company, that the dye sold to the plaintiff was not Direct Blue 290 but in fact "a mixture of Direct Blue 218(majority) and Direct Red 81 and Blue 86".
27 Dr Chisholm stated that Direct Blue 218 is a known carcinogen whose use has been banned in many countries including within the European Economic Community, Japan, Australia, New Zealand, Thailand and Indonesia. On 21 July 2005 he advised Mr Ajay Choksi that he anticipated serious claims against the plaintiff as well as damage to its reputation as a result of the supply of the wrong dye. Dr Chisholm stated:
In 2006 I travelled to Indonesia a number of times and had discussions with Hendra Amin of Indoasia and Anton of Pindo Delhi about this issue. They told me Pindo Delhi was making a claim against the plaintiff as follows:
(a) By Canpoint selling this banned dye our total sales to the Sinar Mas Group (who owned the mill) could be stopped. At this point the sales are USD500,000/year, with a potential for us to obtain sales of USD 5 million.
(b) We had endangered the lives of their personal [sic] by exposing the mill personal [sic] to a carcinogen - typically when using the people get covered in dye on skin which is absorbed and is a known cause of bladder cancer in males.
(c) The Japan mill's customer was returning 72mt of paper dyed with our Cancolor Blue 2R, worth around USD350,000 total cost.
28 Dr Chisholm anticipated that, in addition to the return of paper, the plaintiff would be subject to claims for supplying dye purporting to be Direct Blue 290 when in fact it was a banned carcinogen, Direct Blue 218. Dr Chisholm estimated this second part of the offsetting claim to be in the order of USD712,400.00 comprising USD19,000 for air travel, USD2,400 for 12 nights accommodation, USD8,000 for meals and entertainment, USD280,000 for paper, USD333,000 for loss of business in the Sinar Mas Group and other, unspecified, costs of USD70,000.
29 As the authorities discussed above make clear, the supporting affidavit must be sufficient in itself to alert the person making the statutory demand to the nature of the case that the company applying to have that demand set aside will be seeking to make. A subsequent affidavit may supplement the case by providing more detail but it may not change the nature of the case to be made. The question here is what the affidavit, as read, reveals to the defendant company.
30 In my view the first affidavit of Dr Chisholm meets the requirements of s 456G. It "promotes the company's case", and clearly stakes out the grounds of the dispute, namely the dual problems of thickening and composition afflicting the dye. Although the affidavit does not annexe invoices from the defendant, it is explicit that the plaintiff was dealing with "Anar" in 2005, after the incorporation of the defendant. The area of controversy has, by necessary inference, been clearly delineated; Elm Financial Services [2004] NSWSC 560 at [7]; or is at the very least raised by a reasonably available inference; Hansmar Investments 61 ACSR at 326.
31 While the defendant correctly states that the plaintiff has not identified a specific cause of action with which it pursues its claim, it is apparent from the circumstances described by the affidavit that the claim would be in the nature of breach of contract or of consumer protection legislation. Adopting the language of Emmett J in Sacon Constructions Pty Ltd v Concrite Quarries Pty Ltd (1997) 15 ACLC 1303 at 1305, the affidavit attempts both to explain the nature of the cross-claim and to quantify it. In Sacon, Emmett J held that the supporting affidavit was insufficient, although his Honour observed in obiter at 1305 that, had supplementary material been filed in time, it would have probably satisfied the requirements of s 459G. That material asserted the offsetting claim in that case with significantly less detail than is present in Dr Chisholm's first affidavit in the present application.